Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
about
Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs.Clinical and parasitological factors in parasite persistence after treatment and clinical cure of cutaneous leishmaniasis.Visceral leishmaniasis relapse hazard is linked to reduced miltefosine exposure in patients from Eastern Africa: a population pharmacokinetic/pharmacodynamic study.
P2860
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
@en
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
@nl
type
label
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
@en
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
@nl
prefLabel
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
@en
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
@nl
P2093
P2860
P50
P356
P1476
Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis
@en
P2093
Adriana Navas
Anke E Kip
Eduardo Ortiz
Maria Adelaida Gomez
Nancy Gore Saravia
P2860
P356
10.1128/AAC.02198-16
P407
P577
2017-02-23T00:00:00Z